Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Stanley Lapidus
AddedFeb 15, 2024
UpdatedJun 28, 2026
Stanley Lapidus

Stanley Lapidus

Board Member, Aushon Biosystems

CrunchbaseLinkedIn

Stanley Lapidus's Career

Aushon Biosystems
Aushon Biosystems

Billerica, MA, US

Board Member· Board
Mirvie
Mirvie

South San Francisco, CA, US

Board Member· Board
SynapDx
SynapDx

Lexington, MA, US

Board Member· Board
Daktari Diagnostics
Daktari Diagnostics

Cambridge, MA, US

Board Member· Board
Helomics
Helomics

Pittsburgh, PA, US

Board Member· Board
PathAI
PathAI

Boston, MA, US

Board Member· Board
Cytyc
Cytyc

Marlborough, MA, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Stanley Lapidus's Career

Aushon Biosystems
Aushon Biosystems
Acquired$37.4M02003Billerica, MA, US
Board Member· Board

Leadership at Aushon Biosystems

Bruns GraysonBruns GraysonBoard Member
Bill GearyBill GearyBoard Member
Carmichael RobertsCarmichael RobertsBoard Member
Jim IulianoJim IulianoBoard Member
Tom Mac MahonTom Mac MahonBoard Member
Peter HonkanenPeter HonkanenBoard Member

Similar to Aushon Biosystems

MetabolonMetabolonDurham, NC, USBiomarkers, Diagnosticsest. 2000MetabolonDurham, NC, US · est. 2000

Metabolon, based in Durham, US, leads in metabolomics for biomarker discovery, diagnostics & precision medicine.

Public · $199.7M302
BiophysicalBiophysicalAustin, TX, USHealth Assessmentsest. 2004BiophysicalAustin, TX, US · est. 2004

Biophysical Corporation: Managing and marketing biomarker-based health assessments.

Series A · $8.4M75
QuanterixQuanterixBillerica, MA, USBiomarker Analysisest. 2007QuanterixBillerica, MA, US · est. 2007

Quanterix: Advancing precision health science through digitized biomarker analysis in Lexington, US.

Public · $533.3M125
Solus BiosystemsSolus BiosystemsPalo Alto, CA, USProtein Analysisest. 2001Solus BiosystemsPalo Alto, CA, US · est. 2001

Solus Biosystems develops advanced platforms for measuring protein conformation changes, enhancing pharmaceutical applications.

Pre-Seed · $800k5
Mirvie
Mirvie
Series A$70.4M492019South San Francisco, CA, US
Board Member· Board

Leadership at Mirvie

Maneesh JainManeesh JainCo-Founder & CEO
Naomi KelmanNaomi KelmanBoard Member
Stephen QuakeStephen QuakeCo-Founder
SynapDx
SynapDx
Series B$32.4M112010Lexington, MA, US
Board Member· Board

Leadership at SynapDx

Bob CarpenterBob CarpenterBoard Member
Hemant TanejaHemant TanejaBoard Member
Kevin HrusovskyKevin HrusovskyBoard Member
Daktari Diagnostics
Daktari Diagnostics
Acquired$85.6M02008Cambridge, MA, US
Board Member· Board

Leadership at Daktari Diagnostics

Aaron SandoskiAaron SandoskiBoard Member
David M RubinDavid M RubinBoard Member
Bill RodriguezBill RodriguezFounder
Donald B. HawthorneDonald B. HawthorneBoard Member
Roger KittermanRoger KittermanBoard Member
alexalexBoard Member
Helomics
Helomics
Late Stage Private$211.5M831995Pittsburgh, PA, US
Board Member· Board

Leadership at Helomics

Neil J CampbellNeil J CampbellBoard Member
Paul L. KornblithPaul L. KornblithFounder
Todd DavisTodd DavisBoard Member
Kevin JohnsonKevin JohnsonBoard Member
Jerry VardzelJerry VardzelCEO
PathAI
PathAI
Late Stage Private$355.2M3602016Boston, MA, US
Board Member· Board

Leadership at PathAI

Tiffany FreitasTiffany FreitasChief Operating Officer
Brandon EldredgeBrandon EldredgeChief Financial Officer
Andrew BeckAndrew BeckCo-Founder and CEO
Aditya KhoslaAditya KhoslaCo-Founder
Andrew BeckAndrew BeckCo-Founder
Dr Gail MarcusDr Gail MarcusBoard Member
Cytyc
Cytyc
Acquired$450M02007Marlborough, MA, US
Co-Founder

Leadership at Cytyc

Amy A. WendellAmy A. WendellBoard Member
Patrick SullivanPatrick SullivanBoard Member
Stephen P. MacMillanStephen P. MacMillanBoard Member
Jay SteinJay SteinFounder
Christiana StamoulisChristiana StamoulisBoard Member
Marla S. PerskyMarla S. PerskyBoard Member

Stanley Lapidus's Co-Investors

Michael FinneyMichael FinneyCo-invested · Thrive Bioscience SeedDoug HansenDoug HansenCo-invested · Thrive Bioscience SeedWillard UmphreyWillard UmphreyCo-invested · Thrive Bioscience SeedGuy BroadbentGuy BroadbentCo-invested · Thrive Bioscience SeedNorman SorensenNorman SorensenCo-invested · Thrive Bioscience SeedJerry KarabelasJerry KarabelasCo-invested · Thrive Bioscience SeedJerry KarabelasJerry KarabelasCo-invested · Thrive Bioscience Seed

Stanley Lapidus's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance Retail

People Similar to Stanley Lapidus

Bryan TrusselBryan TrusselBoard Member · GlympseDan KidleDan KidleBoard Member · Jumpcode GenomicsMichael GreeleyMichael GreeleyCo-Founder · Flare Capital PartnersSatish TadikondaSatish TadikondaBoard Member · Blue Cloud VenturesLorin JohnsonLorin JohnsonBoard Member · GlycyxNelson ChanNelson ChanBoard Member · Twist Bioscience